Rigel Pharmaceuticals Inc (RIGL)
25.04
+0.73
(+3.00%)
USD |
NASDAQ |
Nov 21, 16:00
25.11
+0.07
(+0.28%)
After-Hours: 20:00
Rigel Pharmaceuticals Debt to Equity Ratio: -4.083 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
September 30, 2024 | -4.083 |
June 30, 2024 | -1.996 |
March 31, 2024 | -1.885 |
December 31, 2023 | -2.081 |
September 30, 2023 | -1.874 |
June 30, 2023 | -2.119 |
March 31, 2023 | -2.452 |
December 31, 2022 | -2.897 |
September 30, 2022 | -1.990 |
June 30, 2022 | -8.114 |
March 31, 2022 | 4.391 |
December 31, 2021 | 0.6556 |
September 30, 2021 | 0.4004 |
June 30, 2021 | 0.2916 |
March 31, 2021 | 0.2534 |
December 31, 2020 | 0.5823 |
September 30, 2020 | 0.3893 |
June 30, 2020 | 0.3135 |
March 31, 2020 | 0.1252 |
December 31, 2019 | 0.1823 |
September 30, 2019 | 0.1421 |
June 30, 2019 | 0.00 |
March 31, 2019 | 0.00 |
December 31, 2018 | 0.00 |
September 30, 2018 | 0.00 |
Date | Value |
---|---|
June 30, 2018 | 0.00 |
March 31, 2018 | 0.00 |
December 31, 2017 | 0.00 |
September 30, 2017 | 0.00 |
June 30, 2017 | 0.00 |
March 31, 2017 | 0.00 |
December 31, 2016 | 0.00 |
September 30, 2016 | 0.00 |
June 30, 2016 | 0.00 |
March 31, 2016 | 0.00 |
December 31, 2015 | 0.00 |
September 30, 2015 | 0.00 |
June 30, 2015 | 0.00 |
March 31, 2015 | 0.00 |
December 31, 2014 | 0.00 |
September 30, 2014 | 0.00 |
June 30, 2014 | 0.00 |
March 31, 2014 | 0.00 |
December 31, 2013 | 0.00 |
September 30, 2013 | 0.00 |
June 30, 2013 | 0.00 |
March 31, 2013 | 0.00 |
December 31, 2012 | 0.00 |
September 30, 2012 | 0.00 |
June 30, 2012 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-8.114
Minimum
Jun 2022
4.391
Maximum
Mar 2022
-1.095
Average
-0.8745
Median
Debt to Equity Ratio Benchmarks
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 139.42M |
Total Liabilities (Quarterly) | 154.06M |
Shareholders Equity (Quarterly) | -14.64M |
Current Ratio | 1.960 |
Net Debt Paydown Yield | -0.01% |